Autoimmune Hepatitis is a chronic disease in which the body’s immune system attacks the liver and causes inflammation and liver damage. It consists of two clinically relevant types, i.e., Type 1, which is classic and is diagnosed in adulthood, whereas Type 2 is diagnosed during childhood. It may present as either an acute or chronic disease with a fluctuating pattern. However, the spectrum of presentation also includes asymptomatic patients.

Autoimmune Hepatitis Symptoms include fatigue, nausea, abdominal pain, weight loss, light colored stools, dark colored urine, loss of menstruation in women, etc. Without treatment, it might get worse and lead to complications, such as cirrhosis.

DelveInsight’s “Autoimmune Hepatitis Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Autoimmune Hepatitis , historical and forecasted epidemiology as well as the Autoimmune Hepatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Some facts of Autoimmune Hepatitis Market are:

• As per the National Organization for Rare Disorders (NORD), the new cases per year (incidence) are estimated at 1-2 per 100,000, and total cases (prevalence) are approximately 24 per 100,000.
• Most of the available data are on AIH-1. AIH-1 represents about 80% of AIH cases, occurs worldwide, and has a strong female predominance: 75% of affected people are female.
• Autoimmune hepatitis has a female predominance and a bimodal age distribution with 2 peaks, 1 in childhood and another in the 5th decade. However, AIH occurs in all genders and age groups. Also, there have been reports of newly diagnosed AIH in patients 80 years of age.
• The course of AIH is not always benign, hence patients presenting with untreated severe disease are at high risk of death and ~ 40% die within 6 months of diagnosis and those who survive (>40%) develop cirrhosis.

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/autoimmune-hepatitis-market

 

Scope of Autoimmune Hepatitis Report are:

• The report covers the descriptive overview of Autoimmune Hepatitis , explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Autoimmune Hepatitis epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Autoimmune Hepatitis are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Autoimmune Hepatitis market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Autoimmune Hepatitis market

 

The major players covered in the Autoimmune Hepatitis Market are

• Eisai Co., Ltd
• NGM Biopharmaceuticals
• HighTide Therapeutics Inc
• Bausch Health
• Mylan N.V.
• Zydus Cadila
• Amneal Pharmaceuticals
• Alkem Labs
• And Many Others

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/autoimmune-hepatitis-market

 

Key Autoimmune Hepatitis Questions are:

• What was the Autoimmune Hepatitis market share (%) distribution in 2017 and how it would look like in 2030?
• What would be the Autoimmune Hepatitis total market size as well as market size by therapies across the 7MM during the forecast period (2017-2030)?
• What are the key findings pertaining to the market across 7MM and which country will have the largest Autoimmune Hepatitis market size during the forecast period (2017-2030)?
• At what CAGR, the Autoimmune Hepatitis market is expected to grow in 7MM during the forecast period (2017-2030)?
• What would be the Autoimmune Hepatitis market outlook across the 7MM during the forecast period (2017-2030)?
• What would be the Autoimmune Hepatitis market growth till 2030, and what will be the resultant market Size in the year 2030?
• How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/autoimmune-hepatitis-market

 

Table of Contents:

1. Key Insights

2. Executive Summary of Autoimmune Hepatitis

3. Competitive Intelligence Analysis for Autoimmune Hepatitis

4. Autoimmune Hepatitis Market Overview at a Glance

4.1. Autoimmune Hepatitis Total Market Share (%) Distribution in 2017

4.2. Autoimmune Hepatitis Total Market Share (%) Distribution in 2030

5. Autoimmune Hepatitis: Disease Background and Overview

6. Patient Journey

7. Autoimmune Hepatitis Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Autoimmune Hepatitis Treatment

11. Marketed Products

11.1. List of Marketed Products in the 7MM

11.2. Drug Name: Company Name

List to be continued in report

12. Emerging Therapies

List to be continued in report

13. Autoimmune Hepatitis: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Autoimmune Hepatitis

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

 

 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/autoimmune-hepatitis-market